Medefil, Inc.

Medefil, Inc. is a specialty pharmaceutical company founded in 1998 that develops, manufactures, and markets injectable products and prefilled sterile syringes. The company operates a state-of-the-art manufacturing facility and research laboratory in Glendale Heights, Illinois, with a 200,000 sq. ft. expansion underway. Medefil has supplied over one billion sterile prefilled syringe products to the market. The company specializes in IV flush syringes (normal saline and heparin in multiple concentrations) and injectable pharmaceutical products including Atropine Sulfate Injection USP, Sterile Water for Injection USP, Calcium Chloride Injection USP, and Sodium Chloride Injection USP 0.9%. Medefil's business model emphasizes comprehensive injectable product development expertise, high-quality manufacturing capabilities, supply reliability, patient safety, and cost-effective solutions. The company serves healthcare providers requiring critical injectable therapies with a focus on quality assurance, regulatory compliance, and efficient operations. Manufacturing and development capabilities encompass sterile prefilled syringe production across multiple injectable forms.